http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
PDPL PRESCRIPTION DRUG PRODUCT LIST- 16TH EDITION RX DRUG PRODUCT LIST / CUMULATIVE SUPPLEMENT NUMBER 8 / JAN'96 - AUG'96 ACETAMINOPHEN; BUTALBITAL ALPRAZOLAM TABLET; ORAL TABLET; ORAL BUTALBITAL AND ACETAMINOPHEN ALPRAZOLAM - DLT - AB HALSEY 325MG;50MG N89568 001 - ADD - AB NOVOPHARM 2MG N74085 004 - DLT - OCT 05, 1988 - ADD - FEB 26, 1996 - ADD - @ 325MG;50MG N89568 001 - ADD - OCT 05,...
FDA Drug Approvals List- June 1999 Drug Approvals for June 1999 Definitions and Notes June 1999 Original New Drug Applications Original Application #: 020968 Approval Date: 30-JUN-99 Trade Name: MONISTAT DUAL PAK Chemical Type: 3 Therapeutic Potential: S Dosage Form: SUPPOSITORY Applicant: ADVANCED CARE PRODUCTS Active Ingredient(s): MICONAZOLE NITRATE OTC/RX Status: RX Indication(s): TREATMENT OF VULVOVAGINAL...
DDPA August 1996 DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE NDA NUMBER TRADE NAME APPLICANT ACTIVE INGREDIENT(S) APPROVAL DATE (DOSAGE FORM) STRENGTH(S) (CLASSIFICATION) CLASSIFICATION(S) ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 19-640 HUMATROPE LILLY SOMATROPIN, BIOSYNTHETIC 01-AUG-96 (INJECTABLE) INDIANAPOLIS, IN 5MG/VIAL (SUPPL-013) 45285 (NEW INDICATION --...
DDPA June 1996 50-719 HELIDAC KIT PROCTOR GAMBLE PHARM BISMUTH SUBSALICYLATE 05-JUN-96 (TABLET, CHEWABLE; CINCINNATI, OH 262.4MG/TABLET CHEWABLE TABLET; 45241 METRONIDAZOLE CAPSULE) 250MG/TABLET TETRACYCLINE 500MG/CAPSULE (ANTIULCER) 20-593 DEPACON ABBOTT VALPROATE SODIUM 06-JUN-96 (INJECTABLE) ABBOTT PARK, IL EQ 100MG ACID/ML 60064 (ANTICONVULSANT) 20-441 PULMICORT...
August Drug Approvals Original Application #: 020508 Approval Date: 29-AUG-96 Trade Name: LAC-HYDRIN Chemical Type: 3 Therapeutic Potential: S Dosage Form: CREAM Applicant: BRISTOL MYERS CO Active Ingredient(s): AMMONIUM LACTATE OTC/RX Status: RX Indication(s): ICHTHYOSIS VULGARIS AND XEROSIS Original Application #: 020532 Approval Date: 26-AUG-96 Trade Name: IVY BLOCK Chemical Type: 1 Therapeutic...
Drug Approvals for August 1997 Drug Approvals for August 1997 Definitions and Notes August 1997 Original New Drug Applications Original Application #: 020808 Approval Date: 29-AUG-97 Trade Name: VISIPAQUE Chemical Type: 3 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: NYCOMED INC Active Ingredient(s): IODIXANOL OTC/RX Status: RX Indication(s): Intra-arterial - for visceral intra-arterial digital...
Combination drug therapy for peptic ulcer disease - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Combination drug therapy for peptic ulcer disease - [Medication] - Quest Diagnostics Patient Health Library Combination drug therapy for peptic ulcer disease - [Medication] - Quest Diagnostics Patient Health Library Digestion, Antibiotics for Peptic Ulcers,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt 11863 14-Feb-96 BROOKHAVEN NATIONAL LAB "CU-67 BULK RADIOISOTOPIC PRODUCT MANUFACTURED IN UPTON, NEW YORK." 11866 27-Feb-96 ESTEVE QUIMICA SA "ENALAPRIL MALEATE MANUFACTURED IN BARCELONA, SPAIN." 11876 28-Feb-96 GIULINI CHEMIE GMBH "SUCRALFATE POWDER MANUFACTURED IN LUDWIGSHAFEN/RHEIN, GERMANY." 11877 04-Mar-96 CILAG AG "ARTICAINE HYDROCHLORIDE MANUFACTURED IN SCHAFFHAUSEN,...
BioPortfolio Limited The Gastrointestinal Market 2003: New Blockbusters and Competitive Dynamics 1 Gastrointestinal Conditions 1.1 An Introduction to Gastrointestinal Conditions 1.2 Report Objectives 1.3 Worldwide Impact of Gastrointestinal Conditions 1.3.1 Demographic Prevalence Graph 1.1 Percentage of Hospitalizations Due to Gastrointestinal Causes Graph 1.2 Percentage of Diagnostic and Therapeutic...
